Global Noninvasive Cancer Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Noninvasive Cancer Diagnostics Market Overview

• 1.1 Product Overview and Scope of Noninvasive Cancer Diagnostics
• 1.2 Classification of Noninvasive Cancer Diagnostics by Type
  • 1.2.1 Global Noninvasive Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Type in 2019
  • 1.2.3 Clinical Chemistry
  • 1.2.4 Immunochemistry/Immunoassay
  • 1.2.5 Molecular Diagnostics
  • 1.2.6 Others
• 1.3 Global Noninvasive Cancer Diagnostics Market by Application
  • 1.3.1 Overview: Global Noninvasive Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Solid Tumors
  • 1.3.3 Blood Cancer
  • 1.3.4 Lung Cancer
  • 1.3.5 Breast Cancer
  • 1.3.6 Others
• 1.4 Global Noninvasive Cancer Diagnostics Market by Regions
  • 1.4.1 Global Noninvasive Cancer Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Noninvasive Cancer Diagnostics (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Noninvasive Cancer Diagnostics Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Noninvasive Cancer Diagnostics Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Noninvasive Cancer Diagnostics Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Noninvasive Cancer Diagnostics Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Noninvasive Cancer Diagnostics Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Precision Therapeutics, Inc. (U.S.)
  • 2.1.1 Precision Therapeutics, Inc. (U.S.) Details
  • 2.1.2 Precision Therapeutics, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Precision Therapeutics, Inc. (U.S.) SWOT Analysis
  • 2.1.4 Precision Therapeutics, Inc. (U.S.) Product and Services
  • 2.1.5 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Digene Corporation (U.S.)
  • 2.2.1 Digene Corporation (U.S.) Details
  • 2.2.2 Digene Corporation (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Digene Corporation (U.S.) SWOT Analysis
  • 2.2.4 Digene Corporation (U.S.) Product and Services
  • 2.2.5 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 AVIVA Biosciences Corporation (U.S.)
  • 2.3.1 AVIVA Biosciences Corporation (U.S.) Details
  • 2.3.2 AVIVA Biosciences Corporation (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 AVIVA Biosciences Corporation (U.S.) SWOT Analysis
  • 2.3.4 AVIVA Biosciences Corporation (U.S.) Product and Services
  • 2.3.5 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 A&G Pharmaceutical, Inc. (U.S.)
  • 2.4.1 A&G Pharmaceutical, Inc. (U.S.) Details
  • 2.4.2 A&G Pharmaceutical, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 A&G Pharmaceutical, Inc. (U.S.) SWOT Analysis
  • 2.4.4 A&G Pharmaceutical, Inc. (U.S.) Product and Services
  • 2.4.5 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
  • 2.5.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Details
  • 2.5.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) SWOT Analysis
  • 2.5.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Product and Services
  • 2.5.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Affymetrix Inc. (U.S.)
  • 2.6.1 Affymetrix Inc. (U.S.) Details
  • 2.6.2 Affymetrix Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Affymetrix Inc. (U.S.) SWOT Analysis
  • 2.6.4 Affymetrix Inc. (U.S.) Product and Services
  • 2.6.5 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 IVDiagnostics, Inc. (U.S.)
  • 2.7.1 IVDiagnostics, Inc. (U.S.) Details
  • 2.7.2 IVDiagnostics, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 IVDiagnostics, Inc. (U.S.) SWOT Analysis
  • 2.7.4 IVDiagnostics, Inc. (U.S.) Product and Services
  • 2.7.5 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
  • 2.8.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Details
  • 2.8.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) SWOT Analysis
  • 2.8.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Product and Services
  • 2.8.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 BIOVIEW Inc. (U.S.)
  • 2.9.1 BIOVIEW Inc. (U.S.) Details
  • 2.9.2 BIOVIEW Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 BIOVIEW Inc. (U.S.) SWOT Analysis
  • 2.9.4 BIOVIEW Inc. (U.S.) Product and Services
  • 2.9.5 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Gen-Probe Incorporated (U.S.)
  • 2.10.1 Gen-Probe Incorporated (U.S.) Details
  • 2.10.2 Gen-Probe Incorporated (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Gen-Probe Incorporated (U.S.) SWOT Analysis
  • 2.10.4 Gen-Probe Incorporated (U.S.) Product and Services
  • 2.10.5 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Noninvasive Cancer Diagnostics Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Noninvasive Cancer Diagnostics Players Market Share
  • 3.2.2 Top 10 Noninvasive Cancer Diagnostics Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Noninvasive Cancer Diagnostics Revenue and Market Share by Regions
• 4.2 North America Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 4.3 Europe Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 4.5 South America Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

5 North America Noninvasive Cancer Diagnostics Revenue by Countries

• 5.1 North America Noninvasive Cancer Diagnostics Revenue by Countries (2015-2020)
• 5.2 USA Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 5.3 Canada Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

6 Europe Noninvasive Cancer Diagnostics Revenue by Countries

• 6.1 Europe Noninvasive Cancer Diagnostics Revenue by Countries (2015-2020)
• 6.2 Germany Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 6.3 UK Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 6.4 France Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 6.5 Russia Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 6.6 Italy Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Countries

• 7.1 Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Countries (2015-2020)
• 7.2 China Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 7.3 Japan Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 7.4 Korea Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 7.5 India Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

8 South America Noninvasive Cancer Diagnostics Revenue by Countries

• 8.1 South America Noninvasive Cancer Diagnostics Revenue by Countries (2015-2020)
• 8.2 Brazil Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Noninvasive Cancer Diagnostics by Countries

• 9.1 Middle East & Africa Noninvasive Cancer Diagnostics Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 9.3 UAE Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Noninvasive Cancer Diagnostics Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Noninvasive Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
• 10.2 Global Noninvasive Cancer Diagnostics Market Forecast by Type (2019-2024)
• 10.3 Clinical Chemistry Revenue Growth Rate (2015-2025)
• 10.4 Immunochemistry/Immunoassay Revenue Growth Rate (2015-2025)
• 10.5 Molecular Diagnostics Revenue Growth Rate (2015-2025)
• 10.6 Others Revenue Growth Rate (2015-2025)

11 Global Noninvasive Cancer Diagnostics Market Segment by Application

• 11.1 Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2015-2020)
• 11.2 Noninvasive Cancer Diagnostics Market Forecast by Application (2019-2024)
• 11.3 Solid Tumors Revenue Growth (2015-2020)
• 11.4 Blood Cancer Revenue Growth (2015-2020)
• 11.5 Lung Cancer Revenue Growth (2015-2020)
• 11.6 Breast Cancer Revenue Growth (2015-2020)
• 11.7 Others Revenue Growth (2015-2020)

12 Global Noninvasive Cancer Diagnostics Market Size Forecast (2021-2025)

• 12.1 Global Noninvasive Cancer Diagnostics Market Size Forecast (2021-2025)
• 12.2 Global Noninvasive Cancer Diagnostics Market Forecast by Regions (2021-2025)
• 12.3 North America Noninvasive Cancer Diagnostics Revenue Market Forecast (2021-2025)
• 12.4 Europe Noninvasive Cancer Diagnostics Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Noninvasive Cancer Diagnostics Revenue Market Forecast (2021-2025)
• 12.6 South America Noninvasive Cancer Diagnostics Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Noninvasive Cancer Diagnostics Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer